Fujifilm Holdings

Fujifilm’s medical systems division is built on the company’s diagnostic imaging technologies, including its foundational digital X-ray diagnostics business (the firm launched its first X-ray film product in 1936 and introduced the world’s first digital X-ray imaging and diagnostic system in 1983). Its brands include Fuji Computed Radiography and the Synapse digital image sharing system, and it operates in 3 segments: imaging solutions, information solutions and document solutions. In July 2015 the company submitted the 1st module in its premarket approval application for digital breast tomosynthesis as an upgrade for its Aspire Cristalle mammography system.